PSTX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 2.90%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $561,900.00

Poseida Therapeutics Insider Trading History Chart

Poseida Therapeutics Share Price & Price History

^$9.51

▲ +0.02 (0.21%)

As of 12/26/2024 06:41 PM ET

Days: 30 | 90 | 365

Man Who Called Nvidia Says: “Your Retirement Is Inside This Building.”

From Brownstone Research | Ad

In 2016, Jeff Brown called Nvidia at a split-adjusted 66 cents. The company just became the world's third $3 trillion company... And the stock is up massively since Jeff's recommendation.

Now, Jeff has found five under-the-radar stocks which could power your retirement.

Poseida Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/10/2024	Mark J Gergen	Chairman	Sell	30,000	$9.46	$283,800.00	651,291
11/26/2024	Mark J Gergen	Chairman	Sell	30,000	$9.27	$278,100.00	651,291
8/8/2022	Eric Ostertag	Chairman	Buy	142,857	$3.50	$499,999.50	838,824
8/8/2022	Life Sciences Holdings L Malin	Major Shareholder	Buy	2,150,000	$3.50	$7,525,000.00	11,835,673
8/3/2022	Eric Ostertag	Chairman	Sell	160,696	$3.69	$592,968.24	695,967
3/16/2022	Kerry D. Ingalls	COO	Buy	3,000	$3.98	$11,940.00

Why Buffett, Griffin and 100 members of Congress are Piling into this One Investment

From Behind the Markets | Ad

This isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.

Click here for the ticker >>>

SEC Filings (Institutional Ownership Changes) for Poseida Therapeutics (NASDAQ:PSTX)

46.87% of Poseida Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Poseida Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/20/2024	Virtu Financial LLC	13,035	$37K	0.0%	N/A	0.013%
11/19/2024	Barclays PLC	120,464	$0.35M	0.0%	+132.7%	0.124%
11/16/2024	Geode Capital Management LLC	1,617,137	$4.63M	0.0%	-0.3%	1.659%
11/15/2024	Barclays PLC	120,464	$0.35M	0.0%	+132.7%	0.124%
11/15/2024	XTX Topco Ltd	182,888	$0.52M	0.0%	+47.1%	0.188%
11/15/2024	Jane Street Group LLC	103,427	$0.30M	0.0%	-5.2%	0.106%
11/15/2024	Wellington Management Group LLP	308,363	$0.88M	0.0%	-20.4%	0.316%
11/15/2024	State Street Corp	1,710,565	$4.89M	0.0%	+2.3%	1.755%
11/15/2024	Jacobs Levy Equity Management Inc.	811,512	$2.32M	0.0%	-12.5%	0.833%
11/14/2024	Fred Alger Management LLC	128,970	$0.37M	0.0%	N/A	0.132%
11/13/2024	Advantage Alpha Capital Partners LP	99,566	$0.29M	0.1%	N/A	0.102%
11/13/2024	FMR LLC	14,570,078	$41.67M	0.0%	+0.2%	14.950%
11/12/2024	Charles Schwab Investment Management Inc.	567,063	$1.62M	0.0%	+3.9%	0.584%
11/9/2024	Intech Investment Management LLC	16,159	$46K	0.0%	N/A	0.017%
11/8/2024	Connor Clark & Lunn Investment Management Ltd.	359,197	$1.03M	0.0%	+62.8%	0.370%
11/6/2024	Cornercap Investment Counsel Inc.	43,177	$0.12M	0.0%	-45.5%	0.044%
11/2/2024	Privium Fund Management B.V.	77,500	$0.22M	0.1%	N/A	0.080%
10/3/2024	SG Americas Securities LLC	24,417	$70K	0.0%	N/A	0.025%
8/15/2024	Mackenzie Financial Corp	17,616	$51K	0.0%	N/A	0.018%
8/15/2024	The Manufacturers Life Insurance Company	28,520	$83K	0.0%	+14.2%	0.029%
8/15/2024	AQR Capital Management LLC	51,741	$0.15M	0.0%	+376.5%	0.053%
8/14/2024	Squarepoint Ops LLC	82,637	$0.24M	0.0%	N/A	0.085%
8/14/2024	Marshall Wace LLP	10,538	$31K	0.0%	N/A	0.011%
8/12/2024	XTX Topco Ltd	124,301	$0.36M	0.0%	+37.1%	0.128%
8/12/2024	Blair William & Co. IL	1,101,325	$3.22M	0.0%	+14.1%	1.136%
8/9/2024	Renaissance Technologies LLC	854,900	$2.50M	0.0%	+53.4%	0.882%
8/9/2024	Dimensional Fund Advisors LP	599,812	$1.75M	0.0%	+1.6%	0.619%
8/8/2024	American Century Companies Inc.	90,487	$0.26M	0.0%	+5.9%	0.093%
8/6/2024	Acadian Asset Management LLC	399,839	$1.17M	0.0%	+9.4%	0.412%
8/1/2024	Rhumbline Advisers	97,012	$0.28M	0.0%	+4.2%	0.100%
7/31/2024	Rothschild Investment LLC	12,000	$35K	0.0%	N/A	0.012%
7/29/2024	Principal Financial Group Inc.	12,006	$35K	0.0%	N/A	0.012%
7/26/2024	Bank of New York Mellon Corp	228,700	$0.67M	0.0%	+13.0%	0.236%
5/16/2024	Jacobs Levy Equity Management Inc.	830,127	$2.65M	0.0%	+89.4%	0.856%
5/16/2024	Bayesian Capital Management LP	10,200	$33K	0.0%	N/A	0.011%
5/15/2024	Public Employees Retirement System of Ohio	62,945	$0.20M	0.0%	+177.3%	0.065%
5/15/2024	Lazard Asset Management LLC	28,679	$91K	0.0%	+280.3%	0.030%
5/10/2024	Acadian Asset Management LLC	365,518	$1.17M	0.0%	-27.1%	0.377%
5/10/2024	Vanguard Group Inc.	3,373,065	$10.76M	0.0%	+16.3%	3.480%
5/9/2024	Blair William & Co. IL	965,052	$3.08M	0.0%	+41.3%	0.996%
5/8/2024	Russell Investments Group Ltd.	34,503	$0.11M	0.0%	N/A	0.036%
5/7/2024	SG Americas Securities LLC	28,511	$91K	0.0%	-22.9%	0.029%
2/16/2024	Public Employees Retirement System of Ohio	22,700	$76K	0.0%	N/A	0.024%
2/15/2024	Cantor Fitzgerald L. P.	50,205	$0.17M	0.0%	N/A	0.053%
2/13/2024	Tower Research Capital LLC TRC	10,679	$36K	0.0%	+110.5%	0.011%
2/9/2024	Dynamic Technology Lab Private Ltd	10,459	$36K	0.0%	N/A	0.011%
2/1/2024	New York State Common Retirement Fund	22,763	$76K	0.0%	-44.1%	0.024%
2/1/2024	MCF Advisors LLC	247,024	$0.83M	0.1%	+476.4%	0.258%
1/24/2024	Mirae Asset Global Investments Co. Ltd.	114,011	$0.38M	0.0%	-56.1%	0.119%
11/13/2023	Connor Clark & Lunn Investment Management Ltd.	342,857	$0.82M	0.0%	+186.7%	0.394%
11/13/2023	Acadian Asset Management LLC	851,839	$2.03M	0.0%	-23.4%	0.980%
11/13/2023	Silverarc Capital Management LLC	3,567,985	$8.49M	2.6%	+21.1%	4.105%
11/13/2023	FMR LLC	13,037,429	$31.03M	0.0%	+0.2%	14.999%
11/9/2023	Blair William & Co. IL	740,650	$1.76M	0.0%	+30.2%	0.852%
11/7/2023	Barclays PLC	45,542	$0.11M	0.0%	+40.7%	0.052%
11/6/2023	Keystone Financial Group	15,000	$36K	0.0%	N/A	0.017%
10/27/2023	Allspring Global Investments Holdings LLC	12,247	$29K	0.0%	N/A	0.014%
10/26/2023	Mirae Asset Global Investments Co. Ltd.	259,929	$0.62M	0.0%	+10.2%	0.299%
10/26/2023	Strs Ohio	20,100	$47K	0.0%	N/A	0.023%
9/21/2023	Barclays PLC	32,368	$57K	0.0%	-68.4%	0.037%
9/8/2023	Tucker Asset Management LLC	19,096	$34K	0.0%	+156.2%	0.022%
8/15/2023	Silverarc Capital Management LLC	2,945,948	$5.19M	1.6%	+9.5%	3.389%
8/14/2023	Graham Capital Management L.P.	19,038	$34K	0.0%	N/A	0.022%
8/11/2023	Penserra Capital Management LLC	49,027	$86K	0.0%	+142.6%	0.056%
8/7/2023	Acadian Asset Management LLC	1,111,372	$1.95M	0.0%	+9.9%	1.281%
8/4/2023	American International Group Inc.	32,712	$58K	0.0%	N/A	0.038%
8/3/2023	Mackenzie Financial Corp	18,832	$33K	0.0%	N/A	0.022%
7/25/2023	DekaBank Deutsche Girozentrale	100,000	$0.16M	0.0%	+25.0%	0.115%
7/10/2023	SG Americas Securities LLC	31,016	$55K	0.0%	+29.4%	0.036%
6/13/2023	Callan Capital LLC	68,007	$0.21M	0.0%	+9.1%	0.078%
5/15/2023	Globeflex Capital L P	91,246	$0.28M	0.0%	N/A	0.105%
5/11/2023	Acadian Asset Management LLC	1,011,383	$3.12M	0.0%	+406.8%	1.166%
5/11/2023	Cornercap Investment Counsel Inc.	41,008	$0.13M	0.0%	-38.0%	0.047%
5/11/2023	Knott David M Jr	140,921	$0.43M	0.2%	-16.5%	0.162%
5/9/2023	Y Intercept Hong Kong Ltd	43,321	$0.13M	0.0%	N/A	0.050%
5/9/2023	Callan Capital LLC	68,007	$0.21M	0.0%	+9.1%	0.078%
5/4/2023	Barclays PLC	102,545	$0.32M	0.0%	+76.5%	0.118%
5/3/2023	Jump Financial LLC	122,091	$0.38M	0.0%	+88.1%	0.141%
5/1/2023	Virtu Financial LLC	22,806	$70K	0.0%	+28.2%	0.026%
4/28/2023	SG Americas Securities LLC	23,960	$74K	0.0%	N/A	0.028%
4/27/2023	Arizona State Retirement System	13,697	$42K	0.0%	N/A	0.016%
4/24/2023	Penserra Capital Management LLC	20,210	$62K	0.0%	-29.3%	0.023%
4/12/2023	FNY Investment Advisers LLC	10,000	$30K	0.0%	N/A	0.012%
2/14/2023	683 Capital Management LLC	36,966	$0.20M	0.0%	N/A	0.043%
2/13/2023	Callan Capital LLC	62,347	$0.33M	0.0%	N/A	0.073%
2/13/2023	GSA Capital Partners LLP	95,469	$0.51M	0.1%	N/A	0.111%
2/13/2023	Knott David M Jr	168,839	$0.90M	0.3%	+11.6%	0.196%
2/10/2023	HRT Financial LP	200,351	$1.06M	0.0%	N/A	0.233%
2/10/2023	Blair William & Co. IL	19,143	$0.10M	0.0%	+8.5%	0.022%
2/9/2023	Citigroup Inc.	163,675	$0.87M	0.0%	+5,651.1%	0.190%
2/1/2023	Bank of Montreal Can	399,472	$1.62M	0.0%	-22.9%	0.465%
1/31/2023	MCF Advisors LLC	42,854	$0.23M	0.0%	-17.4%	0.050%
11/15/2022	Perceptive Advisors LLC	750,000	$2.65M	0.1%	N/A	0.873%
11/15/2022	EcoR1 Capital LLC	2,650,000	$9.36M	0.3%	N/A	3.083%
11/14/2022	Pentwater Capital Management LP	5,975,000	$21.09M	0.2%	+20.3%	7.222%
11/14/2022	Cormorant Asset Management LP	1,850,000	$6.53M	0.5%	N/A	2.236%
11/14/2022	Ergoteles LLC	93,842	$0.33M	0.0%	-31.2%	0.113%
11/14/2022	Penserra Capital Management LLC	71,587	$0.25M	0.0%	N/A	0.087%
11/14/2022	Crown Advisors Management Inc.	150,000	$0.53M	0.5%	N/A	0.181%
11/14/2022	Forefront Analytics LLC	15,650	$59K	0.0%	-33.0%	0.019%

Data available starting January 2016

Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company's development candidates for Heme Malignancies includes P-BCMA-ALLO1, which is in Phase I trial to treat patients with relapsed/refractory multiple myeloma; P-CD19CD20-ALLO1, which is in Phase I trial for treating B cell malignancies and other autoimmune diseases; P-BCMACD19-ALLO1, an allogeneic, off-the-shelf CAR-T product candidate in preclinical development for treating multiple myeloma; and P-CD70-ALLO1 under preclinical development to treat hematological indications. It is also involved in the development of P-MUC1C-ALLO1 that is in Phase I trial for treating a range of solid tumors, including breast, colorectal, lung, ovarian, pancreatic, and renal cancers; P-PSMA-ALLO1, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in preclinical development for the treatment of patients with metastatic castrate resistant prostate cancer (mCRPC); and P-PSMA-101, an allogeneic CAR-T product candidate under Phase 1 clinical trial for treating mCRPC. In addition, the company engages in the development of P-FVIII-101, a clinical stage liver-directed gene therapy for the in vivo treatment of hemophilia A; P-OTC-101, a clinical stage liver-directed gene therapy for the in vivo treatment of ornithine transcarbamylase deficiency; and P-PAH-101, a clinical stage liver-directed gene therapy for the in vivo treatment of phenylketonuria. It has a research collaboration and license agreement with F. Hoffmann-La Roche Ltd, and Hoffmann-La Roche Inc. The company was incorporated in 2014 and is headquartered in San Diego, California.

Today's Range

Now: $9.51

$9.43

$9.52

50 Day Range

MA: $5.68

$2.37

$9.51

52 Week Range

Now: $9.51

$1.87

$9.58

Volume

647,845 shs

Average Volume

736,557 shs

Market Capitalization

$929.83 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.61

Who are the company insiders with the largest holdings of Poseida Therapeutics?: Poseida Therapeutics' top insider shareholders include:
Mark J Gergen (Chairman)
Learn More about top insider investors at Poseida Therapeutics.
Who are the major institutional investors of Poseida Therapeutics?: Poseida Therapeutics' top institutional investors include:
FMR LLC — 14.95%
State Street Corp — 1.76%
Geode Capital Management LLC — 1.66%
Jacobs Levy Equity Management Inc. — 0.83%
Charles Schwab Investment Management Inc. — 0.58%
Connor Clark & Lunn Investment Management Ltd. — 0.37%
Learn More about top institutional investors of Poseida Therapeutics stock.
Which institutional investors are selling Poseida Therapeutics stock?: Within the previous quarter, PSTX stock was sold by these institutional investors:
Jacobs Levy Equity Management Inc.
Wellington Management Group LLP
Cornercap Investment Counsel Inc.
Jane Street Group LLC
Geode Capital Management LLC
Which institutional investors are buying Poseida Therapeutics stock?: In the previous quarter, PSTX stock was purchased by institutional investors including:
Connor Clark & Lunn Investment Management Ltd.
Fred Alger Management LLC
Advantage Alpha Capital Partners LP
Privium Fund Management B.V.
Barclays PLC
Barclays PLC
XTX Topco Ltd
State Street Corp